These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3565157)

  • 21. [Risk indicators of urinary calculus formation: value of oxalate and citrate excretion in comparison with the oxalate tolerance value].
    Hannak D; Burczyk U; Bartelt U; Kattermann R
    Urologe A; 1989 Jan; 28(1):20-4. PubMed ID: 2922896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Questionable significance of the chemical analysis of a single 24-hour urine sample in recurrent calcium oxalate nephrolithiasis].
    Riess C; Hess B; Binswanger U
    Klin Wochenschr; 1986 May; 64(9):411-6. PubMed ID: 3713110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of cocoa on excretion of oxalate, citrate, magnesium and calcium in the urine of children].
    Lagemann M; Anders D; Graef V; Bödeker RH
    Monatsschr Kinderheilkd; 1985 Oct; 133(10):754-9. PubMed ID: 4069117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formation of renal stones may be prevented by restoring normal urinary composition.
    Pak CY
    Proc Eur Dial Transplant Assoc; 1983; 20():371-85. PubMed ID: 6361751
    [No Abstract]   [Full Text] [Related]  

  • 25. Hyperuricosuric calcium oxalate nephrolithiasis.
    Coe FL
    Kidney Int; 1978 May; 13(5):418-26. PubMed ID: 661071
    [No Abstract]   [Full Text] [Related]  

  • 26. Prevalence of hyperoxaluria in idiopathic calcium oxalate kidney stone disease.
    Baggio B; Gambaro G; Favaro S; Borsatti A
    Nephron; 1983; 35(1):11-4. PubMed ID: 6888620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of meal on the physiological and physicochemical actions of potassium citrate.
    Pak CY; Oh MS; Baker S; Morris JS
    J Urol; 1991 Sep; 146(3):803-5. PubMed ID: 1875495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sex specific factors in recurrent idiopathic calcium urolithiasis].
    Weitbrecht M; Hegemann M; Pfab R; Wieser T
    Urologe A; 1987 May; 26(3):129-32. PubMed ID: 3603898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of inhibitor and nucleator activities in calcium stone formers.
    Duranti E; Imperiali P; Badii M; Capiccioni S; Masi MG; Sasdelli M
    Proc Eur Dial Transplant Assoc; 1983; 20():445-9. PubMed ID: 6657667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of fenquizone on the urinary inhibitors of calcium oxalate urolithiasis.
    Cupisti A; Ciardella F; Morelli E; Dani L; Lupetti S; Luchi S; Meola M; Barsotti G
    Contrib Nephrol; 1987; 58():184-6. PubMed ID: 3691123
    [No Abstract]   [Full Text] [Related]  

  • 33. ACP Best Practice No 181: Chemical pathology clinical investigation and management of nephrolithiasis.
    Reynolds TM
    J Clin Pathol; 2005 Feb; 58(2):134-40. PubMed ID: 15677531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Resorption of oxalic acid in calcium oxalate nephrolithiasis].
    Müller G; Schütte W; Berg W; Möller T
    Z Urol Nephrol; 1987 Jul; 80(7):391-4. PubMed ID: 3660960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of Urine Composition of Patients With Recurrent Nephrolithiasis in Lorestan, Iran.
    Hadian B; Zafar-Mohtashami A; Ghorbani F
    Iran J Kidney Dis; 2018 Jan; 12(1):22-26. PubMed ID: 29421773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contributory metabolic factors in the development of nephrolithiasis in patients with medullary sponge kidney.
    Yagisawa T; Kobayashi C; Hayashi T; Yoshida A; Toma H
    Am J Kidney Dis; 2001 Jun; 37(6):1140-3. PubMed ID: 11382681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypocitraturia as a pathogenic risk factor in the mixed (calcium oxalate/uric acid) renal stones.
    Alvarez Arroyo MV; Traba ML; Rapado A
    Urol Int; 1992; 48(3):342-6. PubMed ID: 1589930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Whewellite and weddellite: toward a different etiopathogenesis. The significance of morphological typing of calculi].
    Daudon M; Réveillaud RJ
    Nephrologie; 1984; 5(5):195-201. PubMed ID: 6531056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The significance of hypocitruria in calcium oxalate induced nephrolithiasis].
    Horváth C; Németh J; Büki B; Vargha P
    Orv Hetil; 1990 Nov; 131(45):2475-8. PubMed ID: 2234941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Renal lithiasis: the internist's viewpoint 1986].
    Jaeger P
    Schweiz Med Wochenschr; 1986 Jul; 116(27-28):902-8. PubMed ID: 3738461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.